| Name | Title | Contact Details |
|---|
Endo Optiks Inc is a Little Silver, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Virginia Physicians is a Glen Allen, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Since day one, we`ve been dedicated to delivering personalized, innovative, and impactful workplace wellness programs. Provant is a health and wellness solutions company that partners with businesses to build cultures of health designed to improve the health, well-being, and productivity of employees while supporting employers with their healthcare affordability agenda. Provant`s Life+ Program combines personalized “high touch” services with powerful social networking tools that link rewards to healthy behaviors and outcomes. The results of these programs: exceptional engagement, improved health, productive employees, and lower costs. Founded in 2001, Provant serves customers of all sizes across the United States, Puerto Rico, Canada, and the Caribbean. Our customizable program is delivered to millions of people and consist of assessment services (e.g. screening services, flu vaccinations), inspirational services (e.g. coaching, lifestyle and condition programs) and reward and reporting services (participation-based and outcome-based programs). Program innovation, customization, and a comprehensive, quality approach to managing health risks are at the cornerstone of everything that we do. Our leadership team consists of seasoned wellness and business professionals with extensive experience in the health promotion, wellness, consumerism, medical, insurance, and hospital arenas. Our commitment to what we do is based on a sincere desire to promote wellness, to partner with our clients, and to work as a team. Improving lives in the process is what makes it all worthwhile.
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Velcera is a Yardley, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.